Villanova Investment Management Co LLC Increases Stock Holdings in DENTSPLY SIRONA Inc. $XRAY

Villanova Investment Management Co LLC boosted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 88.9% in the third quarter, Holdings Channel.com reports. The firm owned 152,913 shares of the medical instruments supplier’s stock after acquiring an additional 71,964 shares during the period. Villanova Investment Management Co LLC’s holdings in DENTSPLY SIRONA were worth $1,940,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of DENTSPLY SIRONA during the first quarter worth about $26,000. Parkside Financial Bank & Trust grew its stake in DENTSPLY SIRONA by 620.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,477 shares in the last quarter. True Wealth Design LLC increased its holdings in DENTSPLY SIRONA by 273.0% during the 2nd quarter. True Wealth Design LLC now owns 2,376 shares of the medical instruments supplier’s stock worth $38,000 after purchasing an additional 1,739 shares during the last quarter. Central Pacific Bank Trust Division raised its position in shares of DENTSPLY SIRONA by 100.0% in the 3rd quarter. Central Pacific Bank Trust Division now owns 4,000 shares of the medical instruments supplier’s stock valued at $51,000 after purchasing an additional 2,000 shares in the last quarter. Finally, Versant Capital Management Inc boosted its stake in shares of DENTSPLY SIRONA by 878.6% during the 3rd quarter. Versant Capital Management Inc now owns 4,883 shares of the medical instruments supplier’s stock valued at $62,000 after buying an additional 4,384 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Insider Transactions at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $11.14, for a total transaction of $915,708.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $12.54 on Monday. The company has a market cap of $2.50 billion, a P/E ratio of -2.84, a PEG ratio of 0.99 and a beta of 1.01. The business has a 50 day moving average of $12.23 and a two-hundred day moving average of $12.47. DENTSPLY SIRONA Inc. has a 52 week low of $9.85 and a 52 week high of $19.27. The company has a quick ratio of 0.99, a current ratio of 1.47 and a debt-to-equity ratio of 1.36.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, January 9th. Shareholders of record on Friday, December 26th were given a $0.16 dividend. The ex-dividend date of this dividend was Friday, December 26th. This represents a $0.64 annualized dividend and a yield of 5.1%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -14.48%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on XRAY shares. JPMorgan Chase & Co. cut their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, November 7th. Barclays assumed coverage on shares of DENTSPLY SIRONA in a research report on Monday, December 8th. They issued an “underweight” rating and a $12.00 target price for the company. Barrington Research reaffirmed an “outperform” rating and set a $14.00 price target on shares of DENTSPLY SIRONA in a research report on Monday, January 5th. Bank of America raised DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $13.00 to $17.00 in a report on Thursday. Finally, Robert W. Baird reduced their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Tuesday, December 16th. Three analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, DENTSPLY SIRONA has an average rating of “Hold” and a consensus target price of $14.46.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.